Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01530867 · ClinicalTrials.gov registry record

Physician-Patient Communication Project

A clinical trial, sponsored by University of California, Los Angeles.

Completed
Registry status
456
Enrollment target

NCT01530867: Completed study, sponsored by University of California, Los Angeles.

NCT01530867 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 456 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01530867 has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
456 participants
Enrollment target

Study Summary

Over half of all Americans take dietary supplements (vitamins, minerals, herbal products) along with their prescription medications. With the economic downturn, dietary supplement sales have surged, perhaps as a result of people attempting to stave off or delay medical care. Supplements are generally thought to be harmless, but some can potentially interact with prescription medications, cause liver or kidney damage, and even adversely affect surgical outcomes. Those substituting dietary supplements for prescription medications also may suffer significant adverse consequences. The United States Food and Drug Administration and the Institute of Medicine recommend that patients considering dietary supplement use consult their providers. Unfortunately, patients fail to disclose dietary supplement use in up to two-thirds of outpatient office visits. To improve discussions, it is important to understand what prompts physicians and patients to communicate about dietary supplements. The overall objectives of this application are to understand how, when and why physicians and patients communicate about dietary supplements, and to assess how patients respond to these discussions. An ethnically diverse group of patients and their physicians will be surveyed and their office visits will be audio recorded. Audio recordings of the visits will be used to assess the relationship of patient and physician attitudes and values, and the physician-patient relationship on dietary supplement discussions. A subset of these patients and physicians will be interviewed to explore how they made decisions to initiate or forgo discussions about supplements. They also will be asked questions concerning the necessity of and responsibility for initiating dietary supplement conversations. Patient responses and reactions to actual discussions also will be explored. Data from observed and reported interactions will be compared to provide a deeper understanding of factors related to disclosure. This

Primary Outcome

Number of patients who disclosed dietary supplement use during audio recorded office visit

Trial Details

FieldValue
Enrollment Target 456 participants
Start Date 2011-11
Est. Completion 2013-05

What the finished NCT01530867 record still lists

NCT01530867 is an observational study that tracks outcomes without assigning an intervention. The registered 456 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01530867 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01530867 about?

NCT01530867 is a clinical study titled "Physician-Patient Communication Project". Over half of all Americans take dietary supplements (vitamins, minerals, herbal products) along with their prescription medications. With the economic downturn, dietary supplement sales have surged, perhaps as a result of people attempting to stave off or delay medical care. Supplements are generall...

What is the current status of trial NCT01530867?

This trial is currently completed. The enrollment target is 456 participants. The study started on 2011-11. Estimated completion is 2013-05.

Who is sponsoring clinical trial NCT01530867?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04462302 · 456 participants · NA

    An Internet-based Program to Help Cancer Survivors Manage Pain

  • NCT05820919 · 456 participants · NA

    Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

  • NCT06254612 · 456 participants · Phase 2

    A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

  • NCT06457841 · 456 participants · NA

    Stress and Resilience

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01530867, the US trial registry maintained by the National Library of Medicine. NCT01530867 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.